Trial Profile
Phase 1, Open-label, Parallel Group, Single-dose Study to Evaluate the Pharmacokinetics, Safety and Tolerability of AAI101 With Cefepime in Subjects With Varying Degrees of Renal Function
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 27 Sep 2018
Price :
$35
*
At a glance
- Drugs AAI101/cefepime (Primary)
- Indications Renal failure; Renal impairment
- Focus Pharmacokinetics
- Sponsors Allecra Therapeutics
- 27 Sep 2018 New trial record